← Evidence map

TrialJournal of the American Society of Nephrology : JASN2021

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.

Glenn M Chertow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

110 papers cite itlatest 60 shown

2021
…
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 34272327